Document Classification

Section Type: RESULTS

Text: The 3-year relapse-free survival rate was 89. 8 % and 89. 3 % (95 % CI = 84. 2 % -95. 3 % and 83. 7 % -94. 8 %, HR = 0. 914, 95 % CI = 0. 42-2. 00 ; P =. 82), and the 3-year metastasis-free survival rate was 91. 7 % and 90. 9 % (95 % CI = 87. 0 % -96. 5 % and 85. 7 % -96. 1 %) for the UNI and WNI groups, respectively (HR = 1. 007, 95 % CI = 0. 44-2. 32 ; P =. 99).